| Jeffrey Legos |
Jeffrey Legos currently works at Pfizer Inc., as Chief Oncology Officer from 2025. |
| James F List |
James F List currently works at Pfizer Inc., as Chief Internal Medicine Officer from 2025. Dr. List also formerly worked at Janssen Global Services LLC, as Global Therapeutic Head-Cardiovascular. Dr. List received his undergraduate degree and graduate degree from Stanford University and doctorate degree from the University of Minnesota. |
| Maria Rivas |
Maria Rivas currently works at The Cooper Cos., Inc., as Independent Director from 2021, New Jersey Performing Arts Center Corp., as Director, 50, as Director from 2021, and Pfizer Inc., as Chief Medical Affairs Officer from 2022. Dr. Rivas also formerly worked at Medidata Solutions, Inc., as Independent Director from 2018 to 2019, Eli Lilly & Co., as Head-Women's Health Medical Affairs from 1999 to 2010, Merck & Co., Inc., as Senior Vice President-Global Medical Affairs from 2016 to 2018, AbbVie, Inc., as Vice President-Global Medical Affairs from 2012 to 2015, EMD Serono, Inc., as Chief Medical Officer & Senior Vice President from 2018 to 2022, Oncology, Inc., as Vice President, Bayer HealthCare, as Vice President-US General Medicine from 2010 to 2012, and Merck KGaA, as Senior VP & Head-Global Medical Affairs from 2016 to 2022. Dr. Rivas received her undergraduate degree from Brandeis University and doctorate degree from Columbia University College of Physicians & Surgeons. |
| Patrizia A. Cavazzoni |
Patrizia A. Cavazzoni currently works at Metropolitan Opera Association, Inc., as Director and Pfizer Inc., as Chief Medical Officer & Executive Vice President from 2025. Dr. Cavazzoni received her doctorate degree from McGill University. |
| Jennifer B. Damico |
Jennifer B. Damico is currently working as a Senior Vice President & Controller at Pfizer Inc. She holds an MBA from Pace University. |
| Albert Bourla |
Albert Bourla currently works at Pfizer Inc., as Chairman & Chief Executive Officer from 2020, Pfizer Ltd., as Chairman & Chief Executive Officer, The Partnership for New York City, Inc., as Co-Chairman, Pharmaceutical Research & Manufacturers of America, as Chairman-Elect from 2024, The Pfizer Foundation, Inc., as Chairman, Biotechnology Innovation Organization, as Director, Catalyst, Inc., as Director from 2019, Healthcare Leadership Council, as Director, Council on Foreign Relations, Inc., as Member, United States Council for International Business, as Trustee, The Business Roundtable, as Member, and The Business Council, as Member. Dr. Bourla also formerly worked at International Federation of Pharmaceutical Manufacturers, as President from 2023 to 2025. Dr. Bourla received his doctorate degree from School of Veterinary Medicine (Greece). |
| Rady A. Johnson |
Rady A. Johnson currently works at Pro Bono Partnership, Inc., as Director, Citizens Crime Commission of New York City, as Director, and Pfizer Inc., as EVP, Chief Compliance, Quality & Risk Officer from 2019. Mr. Johnson also formerly worked at Hogan & Hartson LLP, as Member and Arthur Anderson & Co., as Senior Auditor. Mr. Johnson received his undergraduate degree from the University of Richmond and graduate degree from Georgetown University Law Center. |
| Payal Sahni Becher |
Payal Sahni Becher is currently the Chief People Experience Officer & Executive VP at Pfizer Inc. She started this position in 2022. Prior to her current role, she obtained a graduate degree from Fairleigh Dickinson University and an undergraduate degree from Rider University. |
| Berta Rodriguez-Hervas |
Berta Rodriguez-Hervas currently works at Pfizer Inc., as Chief Artificial Intelligence & Analytics Officer from 2024. Dr. Rodriguez-Hervas also formerly worked at Stellantis NV, as Vice President-AI, Algorithms & Machine Learning. Dr. Rodriguez-Hervas received her doctorate degree from the University of Texas at El Paso. |
| William C. Sessa |
William C. Sessa currently works at Pfizer Inc., as SVP & Chief Scientific Officer-Internal Medicine from 2022. |
| Luis Jodar |
Luis Jodar has a current job as the Chief Medical Officer-Vaccines & Senior VP at Pfizer Inc. |
| Annaliesa Anderson |
Annaliesa Anderson is currently working as the SVP, Head-Vaccine Research & Development at Pfizer Inc. She started this position in 2022. Prior to her current role, Dr. Anderson obtained a doctorate degree from the University of Warwick. |
| Jeff Settleman |
Jeff Settleman currently works at Pfizer Inc., as Co-Chief Scientific Officer-Oncology from 2019. Dr. Settleman also formerly worked at The Massachusetts General Hospital, as Director-Scientific & Molecular Therapeutics, Harvard Medical School, as Professor, Calico LLC, as Head-Oncology Research, and Trillium Therapeutics, Inc., as Member. Dr. Settleman received his undergraduate degree from the University of Pennsylvania and doctorate degree from Yale University. |
| Michael Mcdermott |
Michael Mcdermott currently works at Pfizer Inc., as EVP, Chief Global Supply & Quality Officer Officer from 2022 and Pharmaceutical Manufacturers Association of America, as Member. Mr. Mcdermott also formerly worked at People-To-People, Inc., as Director and Wyeth Holdings LLC, as Vice President-Site Operations from 2007 to 2009. Mr. Mcdermott received his undergraduate degree and graduate degree from New Jersey Institute of Technology. |
| Aamir Malik |
Aamir Malik currently works at Pfizer Inc., as Chief Commercial Officer-US & Executive VP from 2023. Mr. Malik also formerly worked at McKinsey & Co., Inc., as Managing Partner from 1997 to 2021 and Kelley School of Business, as Member-Dean's Council. Mr. Malik received his undergraduate degree from Indiana University. |
| Patrice Ettinger |
Patrice Ettinger is currently the Director at the International Association of Privacy Professionals and the Chief Privacy Officer at Pfizer Inc. |
| Chris Boshoff |
Chris Boshoff currently works at Pfizer Inc., as President-R&D & Chief Scientific Officer from 2025, Seagen, Inc., as President from 2023, and Pfizer (La Jolla), as Vice President-Translational Oncology. Dr. Boshoff also formerly worked at Advanced Oncotherapy Plc, as Non-Executive Director in 2013 and UCL Cancer Institute Research Trust, as Founding Director. Dr. Boshoff received his doctorate degree from Institute of Cancer Research Royal Marsden Hospital. |
| Christopher J. Stevo |
Christopher J. Stevo currently works at Teva Pharmaceutical Industries Ltd., as SVP-Investor Relations & Competitive Intelligence. Mr. Stevo also formerly worked at Amundi Asset Management US, Inc., as Vice President & Senior Equity Analyst from 2012 to 2020, Alexion Pharmaceuticals, Inc., as Head-Investor Relations1 from 2020 to 2021, Enron Corp., as Analyst in 1997, Putnam Investment Management LLC, as Senior Vice President & Portfolio Manager from 2011 to 2012, and Pfizer Inc., as Chief Investor Relations Officer & Senior VP from 2021 to 2024. Mr. Stevo received his Masters Business Admin degree in 1999 from The University of Chicago Booth School of Business and undergraduate degree in 1994 from The Wharton School of the University of Pennsylvania. |
| Alexandre de Germay |
Alexandre de Germay currently works at Pfizer Inc., as Chief International Commercial Officer & EVP from 2023. Mr. de Germay also formerly worked at Laboratoires Majorelle SAS, as Co-Chief Executive Officer from 2021 to 2023 and Sanofi, as Senior Vice President & Global Head-Cardiovascular. Mr. de Germay received his graduate degree from Université Sorbonne Paris Nord. |
| David M. Denton |
David M. Denton currently works at Pfizer Inc., as Chief Financial Officer & Executive Vice President from 2022. Mr. Denton also formerly worked at Tapestry, Inc., as Independent Director from 2014 to 2023, Haleon Plc, as Non-Executive Director from 2023 to 2024, Lowe's Companies, Inc., as Chief Financial Officer & Executive Vice President from 2020 to 2022, CVS Health Corp., as Chief Financial Officer & Executive Vice President from 2010 to 2018, CVS Pharmacy, Inc., as Chief Financial Officer & Executive Vice President in 2008, and Caremark PhC LLC, as Chief Financial Officer & Controller from 2005 to 2007. Mr. Denton received his undergraduate degree from Kansas State University and Masters Business Admin degree from The Wake Forest University School of Business. |
| Sally Susman |
Sally Susman currently works at The Pfizer Foundation, Inc., as Vice Chairman, International Rescue Committee, Inc., as Co-Chairman, Parsons The New School for Design, as Director, U.S.-India Business Council, as Director, National Partnership for Women & Families, as Director, Alzheimers Drug Discovery Foundation, as Director, The Library of Congress Trust Fund Board, as Director, UL LLC, as Director from 2022, UL Solutions, Inc., as Independent Director from 2022, Pfizer Inc., as Chief Corporate Affairs Officer & Executive VP from 2013, Connecticut College, as Trustee, Council on Foreign Relations, Inc., as Member, New York City Commission on State Parks, as Commissioner, and American Theatre Wing, Inc., as Trustee. Ms. Susman also formerly worked at US Department of State (District of columbia), as Director-International Council from 1993 to 1995, The New York Botanical Garden, as Director, WPP Plc, as Independent Non-Executive Director, The Estée Lauder Companies, Inc., as Executive Vice President-Global Communications in 2008, Equity Office Properties Trust, as Trustee from 2005 to 2007, US Department of Commerce (District of columbia), as Deputy Assistant Secretary, and US Senate Committee on Commerce, Science & Transportation, as Legislative Assistant. Ms. Susman received her undergraduate degree from Connecticut College. |
| Douglas M. Lankler |
Douglas M. Lankler currently works at Wyeth LLC, as EVP, Chief Compliance & Risk Officer and Pfizer Inc., as Chief Legal Officer & Executive Vice President from 2014. Mr. Lankler also formerly worked at US Department of Justice, as Assistant Attorney. Mr. Lankler received his undergraduate degree from The State University of New York and graduate degree from Cornell Law School. |
| Lidia L. Fonseca |
Lidia L. Fonseca currently works at The U.S.-Japan Business Council, Inc., as Director, Medtronic Plc, as Independent Director from 2022, Q Squared Solutions Holdings Ltd., as Director, Pfizer Inc., as Executive VP, Chief Technology & Digital Officer from 2019, and Pegasus Tech Ventures Inc., as Advisor. Ms. Fonseca also formerly worked at TEGNA, Inc., as Independent Director from 2014 to 2023, Gannett Co., Inc., as Director from 2014 to 2016, Q2 Solutions Co., as Director from 2016 to 2018, Laboratory Corp. of America Holdings, as Chief Information Officer & Senior Vice President from 2008 to 2013, Quest Diagnostics, Inc., as Chief Information Officer & Senior Vice President from 2014 to 2018, Philips Medical Systems, as Chief Information Officer from 1997 to 2005, Synexus Compass, Inc., as Executive VP-Global Operations & Technology in 2008, Nuclear Medicine Professionals, Inc., as Vice President-Supply Chain Management, and Synaptic Health Alliance, as Founding Member. Ms. Fonseca received her undergraduate degree from the University of California, Berkeley and Masters Business Admin degree from Rotterdam School of Management. |
| Dan R. Littman |
Dan R. Littman is the founder of Orca Pharmaceuticals Ltd. (2012), Vedanta Biosciences, Inc. (2010), and Immunai, Inc. (2018). Current jobs include Independent Director at Pfizer Inc. since 2018, Scientific Advisory Board at ChemoCentryx, Inc., Member of the National Academy of Sciences, Member of the National Academy of Medicine (United States), Venture Partner at Catalio Capital Management LP, and Professor at NYU Langone Health since 1995. Former job includes Professor-Microbiology & Immunology at the University of California from 1985 to 1995. Education includes an undergraduate degree from Princeton University and a doctorate from Washington University School of Medicine. |
| Suzanne Nora Johnson |
Ms. Suzanne N. Johnson is an Independent Director at Pfizer Inc., a Chairman at Intuit, Inc., a Chairman at The John & Mary R. Markle Foundation, Inc., a Co-Chairman-Trustees Board at The Brookings Institution, a Member at American Academy of Arts & Sciences, a Member at Global Agenda Council, a Member at The World Economic Forum USA, Inc. and a Treasurer & Director at TechnoServe, Inc. She is on the Board of Directors at Pfizer, Inc. /Uppsala Ops/, Pfizer Inc., Americas Frontier Fund, American Red Cross, Inc., TechnoServe, Inc. and University of Southern California. Ms. Johnson was previously employed as an Independent Director by American International Group, Inc., an Independent Director by Visa, Inc., a Vice Chairman by The Goldman Sachs Group, Inc., a Co-Chair-Trustees Board by Carnegie Institution of Washington, a Chairman by Global Markets Institute, and a Member-Governors Board by The American National Red Cross. She also served on the board at The Goldman Sachs Foundation. She received her undergraduate degree from the University of Southern California and a graduate degree from Harvard Law School. |
| Joseph J. Echevarria |
Joseph J. Echevarria currently works at the University of Miami, as President, Chief Executive Officer & Trustee from 2022, The Bank of New York Mellon Corp., as Non-Executive Chairman from 2019, My Brother'S Keeper Alliance, as Chairman, Pfizer Inc., as Independent Director from 2015, Unum Group, as Independent Director from 2016, and Xerox (Nederland) BV, as Director from 2017. Mr. Echevarria also formerly worked at Deloitte LLP (New York), as Chief Executive Officer from 2011 to 2014, University of Miami Health System, as Chief Executive Officer, Xerox Corp., as Director, Xerox Holdings Corp., as Independent Director from 2017 to 2023, the University of Miami, as Trustee from 2012 to 2019, US Election Assistance Commission, as Member, and President's Export Council, as Member. Mr. Echevarria received his undergraduate degree in 1978 from the University of Miami. |
| James Quincey |
James Quincey currently works at The Coca-Cola Co., as Chairman & Chief Executive Officer from 2019, Pfizer Inc., as Independent Director from 2020, Special Olympics, Inc., as Director, Chamber of Commerce of The United States of America, as Director, US-China Business Council, as Director, Atlanta Committee for Progress, as Director, and The Business Roundtable, as Member. Mr. Quincey also formerly worked at The Consumer Goods Forum, as Co-Chairman from 2021 to 2023, Fresh Trading Ltd., as Director, and Kalchas Group, as Partner-Strategy Consulting. Mr. Quincey received his undergraduate degree from The University of Liverpool. |
| Susan D. Desmond-Hellmann |
Susan D. Desmond-Hellmann currently works at Pfizer Inc., as Independent Director from 2020, Bill & Melinda Gates Medical Research Institute, as Director, Gates Medical Research Institute, as Director, National Resilience, Inc., as Director, Stand Up To Cancer, as Director, OpenAI, Inc., as Director, and GV Management Co. LLC, as Advisor. Dr. Desmond-Hellmann also formerly worked at Gates Foundation Trust, as Chief Executive Officer from 2014 to 2020, Bill & Melinda Gates Foundation Trust (Investment Management), as Chief Executive Officer from 2014 to 2020, Pfizer Inc., as Director in 2020, Procter & Gamble Co., as Independent Director from 2011 to 2017, Affymetrix, Inc., as Director from 2004 to 2009, Meta Platforms, Inc., as Lead Independent Director from 2015 to 2019, Biotechnology Innovation Organization, as Director, Bristol-Myers Squibb Pharmaceutical Research Institute, as Associate Director-Clinical Cancer Research, Genentech, Inc., as President-Product Development from 2005 to 2009, Howard Hughes Medical Institute, Inc., as Trustee, The University of California, San Francisco, as Chancellor from 2009 to 2014, and BDT Capital LLC, as Senior Advisor. Dr. Desmond-Hellmann received her graduate degree from the University of California, Berkeley and undergraduate degree and doctorate degree from the University of Nevada. |
| James C. Smith |
James C. Smith currently works at Refinitiv Transaction Services Ltd., as President & Chief Executive Officer from 2012, Thomson Reuters Foundation, as Chairman, Pfizer Inc., as Independent Director from 2014, Brazil US Business Council, as Director, Partnering Against Corruption Initiative, as Director, King (Cayman) Holdings Ltd., as Director, The Brookings Institution, as Trustee, The World Economic Forum USA, Inc., as Member-International Business Council, and Marshall University, as Member-Governors Board. Mr. Smith also formerly worked at Cengage Learning, Inc., as President & CEO-Academic & Reference Group, Thomson Reuters Corp., as President & Non-Independent Director in 2020, Refinitiv Ltd., as Director, Thomson Corp., as Chief Operating Officer, Thomson Newspapers Ltd., as Head-Operations, and Forum Mondial de L'Economie, as Member-International Business Council. Mr. Smith received his undergraduate degree from Marshall University. |
| Scott Gottlieb |
Scott Gottlieb currently works at Illumina, Inc., as Non-Executive Chairman from 2025, Pfizer Inc., as Independent Director from 2019, Wesleyan University, as Director, and various other companies. Dr. Gottlieb also formerly worked at CombiMatrix Corp., as Independent Director from 2009 to 2016, T.R. Winston & Co. LLC, as Managing Director from 2013 to 2017, Bravo Health, Inc., as Independent Member of the Board of Directors from 2009 to 2011, and various other companies. Dr. Gottlieb received his undergraduate degree from Wesleyan University and doctorate degree from Icahn School of Medicine at Mount Sinai. |
| Shantanu Narayen |
Shantanu Narayen is the founder of Pictra, Inc. (1996). Mr. Narayen is currently the Chairman & Chief Executive Officer of Adobe, Inc. since 2021, Chairman & Chief Executive Officer of Adobe Systems Romania SRL, Chairman of Adobe Foundation, Vice Chairman of US India Strategic Partnership Forum, Lead Independent Director of Pfizer Inc. since 2013, and Director of Adobe Systems Software Ireland Ltd. Former positions include Independent Director at Dell, Inc. from 2011 to 2013, Director-Desktop & Collaboration Products at Silicon Graphics, Inc., Director at Metavante Technologies, Inc. from 2007 to 2009, and Principal at Apple, Inc. Education includes a graduate degree from Bowling Green State University, an undergraduate degree from Osmania University, and an MBA from Haas School of Business. |
| Susan J. Hockfield |
Susan J. Hockfield currently works at Advanced Manufacturing Partnership Steering Committee, as Co-Chairman, Pfizer Inc., as Independent Director from 2020, Whitehead Institute for Biomedical Research, as Director, Mass General Brigham, Inc., as Director, The Charles Stark Draper Laboratory, Inc., as Director, Boston Symphony Orchestra, Inc., as Director, Repertoire Immune Medicines, Inc., as Director from 2021, Commonwealth Cancer Consortium, Inc., as Director, Massachusetts Institute of Technology, as President from 2004 to 2012, American Academy of Arts & Sciences, as Member, American Association for the Advancement of Science, as Member, Society For Neuroscience, as Member, Myanmar International Trading Corp, as Member, and MIT Corp. (United States), as Member. Dr. Hockfield also formerly worked at GE Aerospace, as Independent Director from 2011 to 2018, QUALCOMM, Inc., as Independent Director from 2012 to 2016, The National Geographic Society, Inc., as Director in 2012, WGBH Educational Foundation, as Director, Council on Foreign Relations, Inc., as Director, Woods Hole Oceanographic Institution, as Director in 2011, Carnegie Corp. of New York, as Trustee, Yale University, as Dean from 1998 to 2002, and Forum Mondial de L'Economie, as Member-Management Board. Dr. Hockfield received her undergraduate degree from Rochester Christian University and doctorate degree from Georgetown University School of Medicine. |
| Ronald Edward Blaylock |
Ronald Edward Blaylock is the founder of GenNx360 Management Company LLC, serving as Managing Partner since 2006. Current jobs include Chairman at ITsavvy LLC, Independent Director at W.R. Berkley Corp. since 2001, Independent Director at Pfizer Inc. since 2017, Director at Congressional Black Caucus Foundation, Inc., Director at Harbourton Mortgage Investment Corp., Director at Syncreon International Group Ulc since 2009, Director at Novel Ingredient Services LLC, Director at Mebane Charitable Foundation, Director at B2B, Trustee at New York University, Trustee at Prep for Prep, Member-Overseers Board at The Leonard N Stern School of Business, and Trustee at The Carnegie Hall Corp. Former jobs include Chairman & Chief Executive Officer at Blaylock & Co, Inc., Chairman at Miller Environmental Group, Inc., Director at FHC Delaware, Inc., Independent Director at Urban One, Inc. from 2012 to 2019, Director at Covenant House, Independent Director at CarMax, Inc. from 2007 to 2025, Director at Inner-City Scholarship Fund, Director at syncreon. US, Inc., Director at syncreon Global Holdings Ltd., Director at Conyers Park II Acquisition Corp., Director at The Mental Health Coalition Inc, Independent Director at Advantage Solutions, Inc. (California) from 2017 to 2022, Principal at UBS Americas, Inc., Principal at Citigroup Global Markets, Inc. (Broker), Principal at PaineWebber, Inc., Trustee at Georgetown University, Trustee at National Association of Basketball Coaches, Trustee at The Carnegie Hall Society, Inc., and Trustee at Ballet Theatre Foundation, Inc. Education includes an undergraduate degree from Georgetown University and an MBA from The Leonard N Stern School of Business. |
